Medical abortion for Australian women: it's time
de Costa, Caroline M. (2005) Medical abortion for Australian women: it's time. Medical Journal of Australia, 183 (7). pp. 378-380.
|PDF (Published Version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://www.mja.com.au/public/issues/183_...
Medical termination of pregnancy with mifepristone, a progesterone antagonist, is available to women in North America, the United Kingdom, much of Western Europe, Russia, China, Israel, New Zealand, Turkey and Tunisia, but not Australia. Experience of mifepristone use in around two million abortions has shown that it is safe, effective, cheap to produce, and highly acceptable to women. Mifepristone is usually used in combination with a prostaglandin analogue, such as misoprostol; these drugs have been added to the World Health Organization’s list of essential medicines for developing countries. Availability of this drug in Australia might largely overcome many of the inequities of access to abortion, and is critical for many women in rural areas and women in some ethnic groups whose access to surgical abortion is limited
|Item Type:||Article (Refereed Research - C1)|
Reproduced with permission from Medical Journal of Australia.
|Keywords:||abortion; Mifepristone; RU-486; termination|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1114 Paediatrics and Reproductive Medicine > 111402 Obstetrics and Gynaecology @ 100%|
|SEO Codes:||92 HEALTH > 9205 Specific Population Health (excl. Indigenous Health) > 920507 Womens Health @ 100%|
|Deposited On:||17 Feb 2010 09:32|
|Last Modified:||18 Oct 2013 00:51|
Last 12 Months: 6
|Citation Counts with External Providers:|
Repository Staff Only: item control page